Latest Articles

Publication Date
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - The AI Journal

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer The AI Journal

Published: Oct. 18, 2025, 10:20 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - GlobeNewswire

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer GlobeNewswire

Published: Oct. 18, 2025, 10 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Yahoo Finance

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Yahoo Finance

Published: Oct. 18, 2025, 10 a.m.
AKR1B1 and AKR1B10 as prognostic markers in endometrial cancer - BioWorld MedTech

AKR1B1 and AKR1B10 as prognostic markers in endometrial cancer BioWorld MedTech

Published: Oct. 17, 2025, 1 p.m.
A Common Pain Relief Drug May Have Anti-Cancer Properties - ScienceAlert

A Common Pain Relief Drug May Have Anti-Cancer Properties ScienceAlert

Published: Oct. 17, 2025, 1:21 a.m.
Ibuprofen: how an everyday drug might offer protection against cancer - The Conversation

Ibuprofen: how an everyday drug might offer protection against cancer The Conversation

Published: Oct. 16, 2025, 5:36 p.m.
Women with metabolic syndrome face higher risk of gynaecological cancers, finds study - The Hindu

Women with metabolic syndrome face higher risk of gynaecological cancers, finds study The Hindu

Published: Oct. 16, 2025, 4:18 p.m.
Long-Term Benefit of Adjuvant Therapy for Endometrial Cancer Patients - Labroots

Long-Term Benefit of Adjuvant Therapy for Endometrial Cancer Patients Labroots

Published: Oct. 16, 2025, 10 a.m.
Circulating biomarkers of infection and endometrial cancer risk - springermedicine.com

Circulating biomarkers of infection and endometrial cancer risk springermedicine.com

Published: Oct. 16, 2025, 2:26 a.m.
Dr Pillay: Endometrial cancer on the rise - The Fiji Times

Dr Pillay: Endometrial cancer on the rise The Fiji Times

Published: Oct. 16, 2025, 12:31 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!